Pharmaceutical

Mon, 12/06/2017 - 07:30
Coventry, UK, 12th June 2017 / Sciad Newswire / Medherant Ltd, a University of Warwick spin-out company developing a nov
Tue, 06/06/2017 - 07:30
Coventry, UK, 6th June 2017 / Sciad Newswire / Medherant Ltd, a University of Warwick spin-out company developing a nove
Wed, 17/05/2017 - 13:00
New, fully integrated systems to include data reporting and visualization, reproduction of assay workflows, ELN and registration tools
Mon, 08/05/2017 - 07:30
Coventry, UK, 8th May 2017 / Sciad Newswire / Medherant Ltd, a University of Warwick spin-out company developing a novel
Thu, 30/03/2017 - 16:00
London, UK and Washington D.C, USA, 30th March 2017 / Sciad Newswire / Oppilotech Ltd, a biopharmaceutical start-up compa
Thu, 30/03/2017 - 10:00
Cambridge, UK, 30th March 2017 / Sciad Newswire / Domainex Ltd, a privately-owned drug discovery services company, is ple
Wed, 15/03/2017 - 10:10
Moncton, Canada, 15th March 2017 / Sciad Newswire / The Atlantic Cancer Research Institute (ACRI) is pleased to announc
Tue, 21/02/2017 - 07:30
Cleveland, UK, 21st February 2017 / Sciad Newswire / Cambridge Research Biochemicals® (CRB), a longstanding
Wed, 04/01/2017 - 07:00
Prokarium and Probiomed today announced the start of their collaboration to scale-up the manufacture of orally administered vaccines in a formulation that would enable stability at 40°C for several weeks. The first vaccine to be manufactured will be developed to prevent so-called ‘Montezuma’s revenge’ or diarrhoea, which affects the local population as well travellers in Mexico and many countries.

Pages